Milne Jill C. bought BCRX
February 27, 2026 · Form 4 insider transaction
Milne Jill C. bought 528 shares of BioCryst Pharmaceuticals, Inc. at $8.75 per share, a transaction worth $4.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
528
Price
$8.75
Total value
$4.6K
InsiderMilne Jill C.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after15,382
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of Common Stock issued to the reporting person in lieu of 100% of the prorated quarterly cash Board Member retainer of $4,625.